Clinical Trial Update: Intranasal Ketamine for Anxiolysis in Pediatric Emergency Department Patients [Phase 4]

View source ↗

Summary

Phase 4 trial update on intranasal ketamine for anxiolysis in pediatric emergency department patients; study terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Lymphoblastic Leukemia
• Anxiety
• Procedural Anxiety

Drugs mentioned

• Intranasal ketamine (ketamine)

Snippet

Sponsor: Brooke Army Medical Center | Conditions: Anxiety, Pediatric ALL | Phase 4 | Status: TERMINATED